BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 33709984)

  • 1. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis.
    Rodriguez CEB; Ouyang L; Kandasamy R
    Behav Pharmacol; 2022 Apr; 33(2&3):130-157. PubMed ID: 33709984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neurotherapeutic Arsenal in
    Al-Khazaleh AK; Zhou X; Bhuyan DJ; Münch GW; Al-Dalabeeh EA; Jaye K; Chang D
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
    Baron EP
    Headache; 2018 Jul; 58(7):1139-1186. PubMed ID: 30152161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction.
    Blanton H; Yin L; Duong J; Benamar K
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles.
    Birenboim M; Chalupowicz D; Maurer D; Barel S; Chen Y; Fallik E; Paz-Kagan T; Rapaport T; Sadeh A; Kengisbuch D; Shimshoni JA
    Phytochemistry; 2022 Aug; 200():113215. PubMed ID: 35483556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Anti-Cancer and Anti-Inflammatory Properties of 25 High-THC Cannabis Extracts.
    Li D; Ilnytskyy Y; Ghasemi Gojani E; Kovalchuk O; Kovalchuk I
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144796
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.
    Eeswara A; Pacheco-Spiewak A; Jergova S; Sagen J
    PLoS One; 2023; 18(3):e0282920. PubMed ID: 36913400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terpenes and Cannabinoids Yields and Profile from Direct-Seeded and Transplanted CBD-
    Zheljazkov VD; Noller JS; Maggi F; Dale R
    J Agric Food Chem; 2022 Aug; 70(34):10417-10428. PubMed ID: 35436102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil.
    Carvalho VM; de Almeida FG; de Macêdo Vieira AC; Rocha ED; Cabral LM; Strongin RM
    Forensic Sci Int; 2022 Jun; 335():111309. PubMed ID: 35462181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
    Fernández N; Cappello MG; Quiroga PN
    Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
    Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
    Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
    Wiley JL; Marusich JA; Blough BE; Namjoshi O; Brackeen M; Akinfiresoye LR; Walker TD; Prioleau C; Barrus DG; Gamage TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jun; 132():110984. PubMed ID: 38417478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
    Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
    [No Abstract]   [Full Text] [Related]  

  • 17. A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.
    Nutt DJ; Phillips LD; Barnes MP; Brander B; Curran HV; Fayaz A; Finn DP; Horsted T; Moltke J; Sakal C; Sharon H; O'Sullivan SE; Williams T; Zorn G; Schlag AK
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):482-500. PubMed ID: 33998895
    [No Abstract]   [Full Text] [Related]  

  • 18. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 19. The antinociceptive activity and mechanism of action of cannabigerol.
    Wen Y; Wang Z; Zhang R; Zhu Y; Lin G; Li R; Zhang J
    Biomed Pharmacother; 2023 Feb; 158():114163. PubMed ID: 36916438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation.
    Raz N; Eyal AM; Zeitouni DB; Hen-Shoval D; Davidson EM; Danieli A; Tauber M; Ben-Chaim Y
    Biochem Pharmacol; 2023 Jun; 212():115548. PubMed ID: 37084981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.